MedTrace Logo

Predictive Factors for a Successful Return to Run After ACL-R

NCT04130308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-10-17

No results posted yet for this study

Summary

After anterior cruciate ligament (LCA) rupture, the recommended treatment for athletes is the surgical reconstruction of the ligament (ACL-R), followed by a long rehabilitation period. The results of this treatment are sub-optimal with a low rate of return to pre-injury level of sport, a high risk of reinjury and early knee osteoarthritis. To improve treatment outcomes, researchers and clinicians recommend optimizing rehabilitation protocols. They recommend individualizing rehabilitation progression based on objective criteria. However, current defined criteria relied on experts' opinions and not scientific validation.

Return to run after ACL reconstruction is an important rehabilitation milestone. It often means the beginning of the return to sport continuum. A successful return to run is therefore crucial for both the patient and clinician. In this study, the investigators aim to determine the predictive outcomes for a successful return to run after ACL-R.

Conditions

  • ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION

Interventions

OTHER

Retrun to run protocol

Progressive return to run protocol for patients after ACL-R

Sponsors & Collaborators

  • Ordre Professionnel de la Physiothérapie du Québec (OPPQ)

    collaborator UNKNOWN

  • Laval University

    lead OTHER

Principal Investigators

  • Jean-Sébastien Roy, PhD · Laval University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04130308 on ClinicalTrials.gov